longbridge
  • Explore
    Products
    Private Wealth ManagementUS StocksSG StocksHK StocksUS OptionsUS Pre-Market OptionsETFsREITsWarrantsCash Plus
    Tools
    Longbridge SkillLongbridge AILongbridge APIPaper TradingDividend HubLongbridge Pro
  • Café
longbridge

KROS

KROS
11.0802.72%( -0.310 )

JF

Justin Frantz

Head of Investor Relations

Justin Frantz is Head of Investor Relations of Keros Therapeutics, Inc.

Positions

  • Company NameKeros Therapeutics, Inc.
    Stock CodeKROS
    PositionHead of Investor Relations
    Colleagues
    • JS
      Jasbir S. SeehraPresident, CEO & Director
    • JB
      Jean-Jacques BienaimeIndependent Chair of the Board
    • EC
      Esther ChoChief Legal Officer & Secretary
    • AT
      Annita TaniniVP of Finance, Corporate Controller and Interim Principal Financial & Accounting Officer
    • LL
      Lorena LernerChief Scientific Officer
    • MA
      Mary Ann GrayIndependent Director
    • AH
      Alpna Hansraj SethIndependent Director
    • JK
      Julius KnowlesIndependent Director
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy